141 related articles for article (PubMed ID: 29635803)
1. Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin.
Landim BC; de Jesus MM; Bosque BP; Zanon RG; da Silva CV; Góes RM; Ribeiro DL
Prostate; 2018 Jul; 78(10):731-742. PubMed ID: 29635803
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucose and palmitate environment on proliferation and migration of PC3-prostate cancer cells.
Rezende LP; Galheigo MRU; Landim BC; Cruz AR; Botelho FV; Zanon RG; Góes RM; Ribeiro DL
Cell Biol Int; 2019 Apr; 43(4):373-383. PubMed ID: 30353973
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth.
Tsutsumi Y; Nomiyama T; Kawanami T; Hamaguchi Y; Terawaki Y; Tanaka T; Murase K; Motonaga R; Tanabe M; Yanase T
PLoS One; 2015; 10(10):e0139709. PubMed ID: 26439622
[TBL] [Abstract][Full Text] [Related]
6. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
8. AKT and AMPK activation after high-fat and high-glucose in vitro treatment of prostate epithelial cells.
Ribeiro DL; Góes RM; Pinto-Fochi ME; Taboga SR; Abrahamsson PA; Dizeyi N
Horm Metab Res; 2014 Jun; 46(7):471-6. PubMed ID: 24799027
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid differentially modulates the cell cycle and metabolism- related genes in tumor and pre-malignant prostate cells.
Tamarindo GH; Góes RM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158766. PubMed ID: 32712248
[TBL] [Abstract][Full Text] [Related]
10. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
11. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
12. Zinc ion dyshomeostasis increases resistance of prostate cancer cells to oxidative stress via upregulation of HIF1α.
Wetherell D; Baldwin GS; Shulkes A; Bolton D; Ischia J; Patel O
Oncotarget; 2018 Feb; 9(9):8463-8477. PubMed ID: 29492208
[TBL] [Abstract][Full Text] [Related]
13. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
14. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.
Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA
Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277
[TBL] [Abstract][Full Text] [Related]
15. Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.
Loubière C; Goiran T; Laurent K; Djabari Z; Tanti JF; Bost F
Oncotarget; 2015 Jun; 6(17):15652-61. PubMed ID: 26002551
[TBL] [Abstract][Full Text] [Related]
16. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
Lim W; Park S; Bazer FW; Song G
J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
[TBL] [Abstract][Full Text] [Related]
18. Metformin-induced activation of AMPK inhibits the proliferation and migration of human aortic smooth muscle cells through upregulation of p53 and IFI16.
Hao B; Xiao Y; Song F; Long X; Huang J; Tian M; Deng S; Wu Q
Int J Mol Med; 2018 Mar; 41(3):1365-1376. PubMed ID: 29286156
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
20. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
